Literature DB >> 15461963

[Contributions and limits of the diagnosis of human African trypanosomiasis].

Vincent Jamonneau1, Philippe Solano, Mathurin Koffi, Mélanie Denizot, Gérard Cuny.   

Abstract

Human African trypanosomiasis, or sleeping sickness, is still a worrying problem in Africa. Sleeping sickness is a disease for which a systematic monitoring is necessary, particularly for the trypanosomiasis caused by Trypanosoma brucei gambiense, which is characterized by a long asymptomatic stage. In the absence of specific clinical signs, mass screening of populations remains the only way to control the disease and to avoid its spreading. The lack of sensitivity and specificity of the diagnosis tests classically used led to the development of molecular tools. PCR amplification of parasite specific sequences has considerably improved the diagnostic of the parasitic infection, the stage diagnosis as well as the post-therapeutic follow-up. But there are limits with a use in routine and research is still necessary to make PCR a real tool for control of sleeping sickness.

Entities:  

Mesh:

Year:  2004        PMID: 15461963     DOI: 10.1051/medsci/20042010871

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  2 in total

1.  Experimental evaluation of xenodiagnosis to detect trypanosomes at low parasitaemia levels in infected hosts.

Authors:  C M Wombou Toukam; P Solano; Z Bengaly; V Jamonneau; B Bucheton
Journal:  Parasite       Date:  2011-11       Impact factor: 3.000

2.  Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.

Authors:  Ipos Ngay Lukusa; Nick Van Reet; Dieudonné Mumba Ngoyi; Erick Mwamba Miaka; Justin Masumu; Pati Patient Pyana; Wilfried Mutombo; Digas Ngolo; Vincent Kobo; Felix Akwaso; Médard Ilunga; Lewis Kaninda; Sylvain Mutanda; Dieudonné Mpoyi Muamba; Olaf Valverde Mordt; Antoine Tarral; Sandra Rembry; Philippe Büscher; Veerle Lejon
Journal:  PLoS Negl Trop Dis       Date:  2021-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.